AREC.L Stock - Arecor Therapeutics plc
Unlock GoAI Insights for AREC.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $5.05M | $4.57M | $2.40M | $1.16M | $1.70M |
| Gross Profit | $1.54M | $4.57M | $2.40M | $1.16M | $1.70M |
| Gross Margin | 30.5% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Income | $-10,697,000 | $-9,175,000 | $-11,660,000 | $-5,977,000 | $-3,428,022 |
| Net Income | $-10,236,000 | $-8,554,000 | $-9,260,000 | $-6,169,000 | $-2,752,367 |
| Net Margin | -202.6% | -187.1% | -385.4% | -532.7% | -162.1% |
| EPS | $-0.31 | $-0.28 | $-0.32 | $-0.27 | $-0.10 |
Arecor Therapeutics PLC, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. The company was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.
Visit WebsiteEarnings History & Surprises
AREC.LEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 30, 2025 | — | $-0.07 | — | — |
Q2 2025 | Apr 22, 2025 | — | $-0.15 | — | — |
Q3 2024 | Sep 26, 2024 | — | $-0.15 | — | — |
Q2 2024 | May 16, 2024 | — | $-0.13 | — | — |
Q3 2023 | Sep 14, 2023 | — | $-0.15 | — | — |
Q2 2023 | Apr 20, 2023 | — | $-0.16 | — | — |
Q3 2022 | Sep 8, 2022 | — | $-0.16 | — | — |
Q2 2022 | Apr 25, 2022 | — | $-0.11 | — | — |
Q3 2021 | Sep 23, 2021 | — | $-0.11 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.06 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.04 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.04 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.04 | — | — |
Q2 2019 | May 31, 2019 | — | $-0.04 | — | — |
Q4 2018 | Nov 30, 2018 | — | $-0.04 | — | — |
Q2 2018 | May 31, 2018 | — | $-0.02 | — | — |
Q4 2017 | Nov 30, 2017 | — | $-0.02 | — | — |
Latest News
Frequently Asked Questions about AREC.L
What is AREC.L's current stock price?
What is the analyst price target for AREC.L?
What sector is Arecor Therapeutics plc in?
What is AREC.L's market cap?
Does AREC.L pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to AREC.L for comparison